Literature DB >> 22653871

DNA hypermethylation in somatic cells correlates with higher reprogramming efficiency.

María J Barrero1, María Berdasco, Ida Paramonov, Josipa Bilic, Marianna Vitaloni, Manel Esteller, Juan Carlos Izpisua Belmonte.   

Abstract

The efficiency of somatic cell reprogramming to pluripotency using defined factors is dramatically affected by the cell type of origin. Here, we show that human keratinocytes, which can be reprogrammed at a higher efficiency than fibroblast [Nat Biotechnol 2008;26:1276-1284], share more genes hypermethylated at CpGs with human embryonic stem cells (ESCs) than other somatic cells frequently used for reprogramming. Moreover, pluripotent cells reprogrammed from keratinocytes (KiPS) are more similar to ESCs than those reprogrammed from fibroblasts (FiPS) in regard to DNA methylation levels, mostly due to the presence of genes that fail to acquire high levels of DNA methylation in FiPS cells. We propose that higher reprogramming efficiency correlates with the hypermethylation of tissue-specific genes rather than with a more permissive pluripotency gene network.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Year:  2012        PMID: 22653871     DOI: 10.1002/stem.1138

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  10 in total

1.  Characterization of the early events leading to totipotency in an Arabidopsis protoplast liquid culture by temporal transcript profiling.

Authors:  Marie-Christine Chupeau; Fabienne Granier; Olivier Pichon; Jean-Pierre Renou; Valérie Gaudin; Yves Chupeau
Journal:  Plant Cell       Date:  2013-07-31       Impact factor: 11.277

Review 2.  Use of human pluripotent stem cells to study and treat retinopathies.

Authors:  Karim Ben M'Barek; Florian Regent; Christelle Monville
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

3.  Tissue and cancer-specific expression of DIEXF is epigenetically mediated by an Alu repeat.

Authors:  Berta Martín; Stella Pappa; Anna Díez-Villanueva; Izaskun Mallona; Joaquín Custodio; María José Barrero; Miguel A Peinado; Mireia Jordà
Journal:  Epigenetics       Date:  2020-02-11       Impact factor: 4.528

Review 4.  Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine.

Authors:  Yuehou Zhang; Wenzhi Hu; Kui Ma; Cuiping Zhang; Xiaobing Fu
Journal:  Stem Cell Rev Rep       Date:  2019-10       Impact factor: 5.739

5.  Stem cells set their sights on retinitis pigmentosa.

Authors:  Jeannette L Bennicelli; Jean Bennett
Journal:  Elife       Date:  2013-08-27       Impact factor: 8.140

6.  Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa.

Authors:  Budd A Tucker; Robert F Mullins; Luan M Streb; Kristin Anfinson; Mari E Eyestone; Emily Kaalberg; Megan J Riker; Arlene V Drack; Terry A Braun; Edwin M Stone
Journal:  Elife       Date:  2013-08-27       Impact factor: 8.140

7.  Targeted expression profiling reveals distinct stages of early canine fibroblast reprogramming are regulated by 2-oxoglutarate hydroxylases.

Authors:  Ian C Tobias; Mian-Mian C Kao; Thomas Parmentier; Hailey Hunter; Jonathan LaMarre; Dean H Betts
Journal:  Stem Cell Res Ther       Date:  2020-12-09       Impact factor: 6.832

Review 8.  An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells.

Authors:  Arnab Ray; Jahnavy Madhukar Joshi; Pradeep Kumar Sundaravadivelu; Khyati Raina; Nibedita Lenka; Vishwas Kaveeshwar; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2021-06-07       Impact factor: 5.739

Review 9.  Epigenetic changes: a common theme in acute myelogenous leukemogenesis.

Authors:  Soraya E Gutierrez; Francisco A Romero-Oliva
Journal:  J Hematol Oncol       Date:  2013-08-13       Impact factor: 17.388

10.  Global indiscriminate methylation in cell-specific gene promoters following reprogramming into human induced pluripotent stem cells.

Authors:  Jonathan Nissenbaum; Ori Bar-Nur; Eyal Ben-David; Nissim Benvenisty
Journal:  Stem Cell Reports       Date:  2013-12-12       Impact factor: 7.765

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.